| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |